Publications

5802 Results

Anti-PD-1/L1 lead-in before MAPK inhibitor combination maximizes antitumor immunity and efficacy

Authors
Y Wang;S Liu;A Algazi;S Lomeli;Y Wang;M Othus;A Hong;Z Wang;C Randolph;A Jones;M Bosenberg;S Byrum;A Tackett;H Lopez;C Yates;D Solit;A Ribas;M Piva;G Moriceau;R Lo
Journal / Conference
Cancer Cell, Aug 18;S1535-6108(21)00402-5. doi: 10.1016/j.ccell.2021.07.023. Online ahead of print.
Year
2021
Research Committee(s)
Melanoma
PMID
PMID34416167
Study Number(s)
S1320

Classical Hodgkin lymphoma [Review]

Authors
P Brice;E de Kerviler;J Friedberg
Journal / Conference
Lancet, Jan 22;S0140-6736(20)32207-8. doi: 10.1016/S0140-6736(20)32207-8. Online ahead of print
Year
2021
Research Committee(s)
Lymphoma
PMID
PMID33493434
Study Number(s)
S0816

Adherence with protocol medication use and mortality from unrelated causes in a prevention trial

Authors
P Pinsky;P Goodman;H Parnes;L Ford;L Minasian
Journal / Conference
Preventive Medicine Dec;153:106778
Year
2021
Research Committee(s)
Cancer Control
PMID
PMID34450188
Study Number(s)
SWOG-9217

Who are the women who enrolled in the POSITIVE trial: A global study to support young hormone receptor positive breast cancer survivors desiring pregnancy

Authors
A Partridge;S Niman;M Ruggeri;F Peccatori;H Azim;M Colleoni;C Saura;C Shimizu;A Saetersdal;J Kroep;A Mailliez;E Warner;V Borges;F Amant;A Gombos;A Kataoka;C Rousset-Jablonski;S Borstnar;J Takei;J Lee;J Walshe;M Ruiz Borrego;HCF Moore;C Saunders;F Cardoso;S Susnjar;V Bjelic-Radisic;K Smith;M Piccart;L Korde;A Goldhirsch;R Gelber;O Pagani
Journal / Conference
Breast, Aug 3;59:327-338. doi: 10.1016/j.breast.2021.07.021. Online ahead of print.
Year
2021
Research Committee(s)
Cancer Survivorship
PMID
PMID34390999
PMC
PMC8365381

Early-onset stage II/III colorectal adenocarcinoma in the IDEA database: Treatment adherence, toxicities, and outcomes from adjuvant fluoropyrimidine and oxaliplatin.

Authors
E Fontana;J Meyers;A Sobrero;A Iveson;AF Shields;J Taieb;T Yoshino;I Souglakos;E Smyth;F Lordick;M Moehler;A Harkin;R LaBianca;J Meyerhardt;T Andre;T Yamanaka;I Boykovinas;A Grothey;I Ben-Aharon
Journal / Conference
J Clin Oncol 39, 2021 (suppl 15; abstr 3517); (ASCO 2021 Annual Meeting), poster discussion
Year
2021
Research Committee(s)
Gastrointestinal
Study Number(s)
CTSU/C80702

Large-scale cross-cancer fine-mapping of the 5p15.33 region reveals multiple independent signals

Authors
H Chen;A Majumdar;L Wang;S Kar;K Brown;H Feng;P Pharoah;R Hung;L Amundadottir;P Kraft;B Pasaniuc;S Lindstrom;Consortium GECCO (C Tangen)
Journal / Conference
HGG Advances Jul 8;2(3):100041
Year
2021
Research Committee(s)
Prevention, Screening, and and Surveillance
PMID
PMID34355204
PMC
PMC8336922
Study Number(s)
S0000

Evaluating Serum Thymidine Kinase 1 in Hormone Receptor Positive Metastatic Breast Cancer Patients Receiving First Line Endocrine Therapy in the SWOG S0226 Trial

Authors
C Paoletti;W Barlow;E Cobain;M Bergqvist;R Mehta;J Gralow;G Hortobagyi;K Albain;L Pusztai;P Sharma;A Godwin;A Thompson;D Hayes;J Rae
Journal / Conference
Clinical Cancer Research, Nov 15;27(22):6115-6123
Year
2021
Research Committee(s)
Breast
PMC
PMID34521624
Study Number(s)
S0226

Breast Cancer in Adolescent and Young Adult Women Under the Age of 40 Years

Authors
E Cathcart-Rake;K Ruddy;WA Bleyer;R Johnson
Journal / Conference
JCO Oncology Practice, Jun;17(6):305-313
Year
2021
Research Committee(s)
Breast and Cancer Care Delivery
PMID
PMID33449828

Clinical and Scientific Impact of National Cancer Institute-Sponsored Clinical Trial Network Group Treatment Trials

Authors
JM Unger;M Leblanc;M Bertagnolli;N Wolmark;W Curran;P O Dwyer;M Schnall;R Mannel;S Mandrekar;J Costantino;R Gray;F Zhao;F Hong;M Bah;R Vaidya;CD Blanke
Journal / Conference
Annals of Oncology 32 (suppl_5): S1102-S1110 (ESMO Annual Meeting (September 16-21, 2021), oral session, abst #1503O
Year
2021
Research Committee(s)
Cancer Care Delivery

Granulomatous and sarcoid-like immune related adverse events (irAEs) following CTLA4 and PD1 blockade adjuvant therapy of high-risk melanoma: A combined analysis of ECOG-ACRIN E1609 and SWOG S1404 Phase III Trials

Authors
A Noor;I Yassine;S Lee;M Othus;J Moon;J Kirkwood;V Sondak;A Ribas;K Grossmann;A Tarhini
Journal / Conference
Annals of Oncology 32 (suppl_5): S867-S905. 10.1016/annonc/annonc706ESMO Annual Meeting (September 16-21, 2021), accepted, E-poster presentation abst #1069P
Year
2021
Research Committee(s)
Melanoma
Study Number(s)
CTSU/E1609, S1404